🔎 Trials Near Me

Pradžia › Atopinis dermatitas (egzema) › Oregon

Atopinis dermatitas (egzema) klinikiniai tyrimai Oregon

6 tyrimai dėl Atopinis dermatitas (egzema) ieško dalyvių vietose Oregon.

Miestai Oregon

Oficialus tyrimo tekstas (anglų kalba)

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Portland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07003425

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 3, Portland
Renkami dalyviai2 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-12 · NCT07037901

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • Oregon Health and Science University /ID# 266483, Portland
Renkami dalyviai3 fazė
Amžius nuo 2 iki 11 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06461897

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  • Leo Pharma Investigational site, Portland
Renkami dalyviai3 fazė
6 Months – 11 Years · Visoms lytims · Atnaujinta 2026-07-07 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • Oregon Health and Science University /ID# 263736, Portland
Renkami dalyviai3 fazė
Amžius nuo 18 iki 63 · Visoms lytims · Atnaujinta 2026-07-06 · NCT06389136

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7073, Gresham
Renkami dalyviaiStebimasis tyrimas
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-03-13 · NCT06988605

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.